Skip to main content
Aging and Disease logoLink to Aging and Disease
. 2022 Feb 1;13(1):8–23. doi: 10.14336/AD.2021.0728

Potential Effect of the Circadian Clock on Erectile Dysfunction

Tao Li 1,#, Yunjin Bai 2,#, Yiting Jiang 3,#, Kehua Jiang 1, Ye Tian 1, Zhen Wang 1, Yong Ban 1, Xiangyi Liang 1, Guangheng Luo 1,*, Fa Sun 1,*
PMCID: PMC8782551  PMID: 35111358

Abstract

The circadian rhythm is an internal timing system, which is generated by circadian clock genes. Because the circadian rhythm regulates numerous cellular, behavioral, and physiological processes, organisms have evolved with intrinsic biological rhythms to adapt the daily environmental changes. A variety of pathological events occur at specific times, while disturbed rhythms can lead to metabolic syndrome, vascular dysfunction, inflammatory disorders, and cancer. Therefore, the circadian clock is considered closely related to various diseases. Recently, accumulated data have shown that the penis is regulated by the circadian clock, while erectile function is impaired by an altered sleep-wake cycle. The circadian rhythm appears to be a novel therapeutic target for preventing and managing erectile dysfunction (ED), although research is still progressing. In this review, we briefly summarize the superficial interactions between the circadian clock and erectile function, while focusing on how disturbed rhythms contribute to risk factors of ED. These risk factors include NO/cGMP pathway, atherosclerosis, diabetes mellitus, lipid abnormalities, testosterone deficiency, as well as dysfunction of endothelial and smooth muscle cells. On the basis of recent findings, we discuss the potential role of the circadian clock for future therapeutic strategies on ED, although further relevant research needs to be performed.

Keywords: circadian clock, disturbed rhythms, penile erection, erectile dysfunction


With the earth’s rotation, the light and the darkness have a 24-h oscillating cycle [1-4]. To adapt to such environmental light/dark changes, all plants and animals have evolved universally internal circadian rhythms [4], while cues that synchronize intrinsic rhythms with external circumstances are called zeitgebers (time givers) [5]. Numerous cellular, physiological, and behavioral biological processes have shown such rhythmic fluctuations within the 24-h cycle [5]. An example of this rhythmic fluctuation is that blood pressure, heart rate, and body temperature rise in the morning, but decline in the evening [5]. Such inherent rhythms are also observed in sleep [6], diet [7], homeostasis [4, 8], and hormone secretion [4, 8].

During the past 100 years, global industrialization and technological advances have improved modern medical science and promoted human health. However, rising rates of numerous diseases have coincided with altered lifestyles and work patterns [9]. Currently, an increased rate of distant travel, widespread use of artificial light, and modern electronic communication systems have become an essential part in daily life [9]. Elevated work or social pressure, and personal habits with entertainment technological communication platforms have led to widespread use of artificial light or luminescent screens [9]. Insomnia, jet lag, long distance travel across multiple time zones, and prolonged shift work are also more frequent [9]. All of these factors greatly change the daily rest/wake cycles and inevitably chronically disrupt intrinsic circadian rhythms [9]. Numerous studies have shown that disturbed sleep or an impaired circadian clock make individuals more vulnerable to hypertension, type 2 diabetes mellitus (T2DM), hyperlipemia, obesity, atherosclerosis, and cancer (e.g., lung, breast, liver, pancreas, ovary, colon, and prostate cancers) [9-12], meanwhile they also induce oxidative stress, promote inflammatory responses, and accelerate coagulatory responses [13]. All these finally lead to profound problems in people’s health and well-being [9].

Erectile dysfunction (ED) is defined as a consistent or recurrent inability to achieve or maintain a sufficient penile erection for a satisfactory sexual performance [14, 15]. It is a common disease [15, 16] and deteriorates the quality of life (QoL) and sexual satisfaction for men and their partners [17, 18]. According to the National Health and Nutrition Examination Survey, 18 million or 18.4% of men aged >20 years suffer from ED in the USA, and the worldwide prevalence will reach 322 million in 2025 [17]. Although the advance of phosphodiesterase type 5 inhibitor (PDE5i) is a landmark significance for ED, many patients are still refractory or failing to respond as anticipated [19]. Therefore, clarifying the patho-physiological mechanisms of ED is essential before attempting to prevent its progress or improve therapeutic effects.

Accumulating evidence has shown that the penis is also influenced by the circadian clock, while disturbed circadian diseases like sleep disorders, jet leg, and shift working promote ED incidence [11]. Treatment of these diseases can reverse impaired erectile function [19, 20]. Meanwhile, ED is mainly regarded as an organic vascular disease with multifactorial risk factors, such as hypertension, diabetes, hyperlipidemia, and athero-sclerosis [21, 22]; all these factors are closely related to disrupted circadian rhythms [5, 9, 23, 24] (Fig. 1). Recent evidence has also suggested that the progression of ED is regulated by circadian disorders [11, 19, 25, 26].

Figure 1.

Figure 1.

Involvement of circadian clock with ED. The disturbed circadian clock is tightly correlated with NO/cGMP pathway, atherosclerosis, diabetes mellitus, lipid abnormalities, testosterone deficiency, and dysfunction of endothelial and smooth muscle cells, all of which is risk factors of ED. SMC: smooth muscle cell; ED: erectile dysfuncton.

Herein, we review the relationship between the circadian clock and ED, we also discuss whether and how disturbed circadian rhythms lead to ED from local cellular events (endothelial and smooth cellular function) and systemic factors (diabetes, hyperlipidemia, and atherosclerosis).

Biological characteristics of the circadian clock

The central circadian clock is located in the suprachiasmatic nucleus (SCN) of anterior hypothalamus [4]. After photic cues from light-dark cycle are perceived by the retina and transmitted to the SCN as electrical signals, the central circadian system synchronizes with geophysical time [4] and feedbacks to the downstream brain regions and periphery via sympathetic nervous system signaling and hormone release [9, 27]. The synchronization factor, also known as the zeitgeber or time giver, varies from environmental temperature, eating/drinking patterns, pharmacological manipulations, to social interactions; however, light is the fundamental one [4, 28-30]. Additionally, peripheral organs like heart, liver, spleen, and lung also function as “peripheral clocks” and regulate cyclic biological functions by manipulating circadian gene transcription, protein synthesis, and cellular behavior [9]. These “peripheral clocks” are proved as the isolated cells in weeks-long culture still maintained circadian rhythms but can be ceased by serum shock [9, 31]. However, the exact interaction between central and peripheral clocks has not yet been fully clarified [1, 4, 32-34].

Approximately 10% of genes are clock-controlled genes (CCGs) with circadian oscillations [10, 11, 35]. Mammals are the most complex, with more than 10 clock genes being discovered [10] including circadian locomotor output cycles kaput (CLOCK), brain and muscle aryl hydrocarbon receptor nuclear translocator-like (BMAL1), the period family (PER1/2/3), cryptochrome 1 and 2 (CRY1/2), orphan nuclear receptor (REV-ERBα), and retinoic acid-related orphan receptor alpha (RORα) [4, 9, 10]. These circadian clock genes regulate the day/night fluctuant cycles [4, 10, 36] by positive and negative feedback loops in the SCN and peripheral tissue [9]. Briefly, CLOCK and BMAL1 form the core transcription factor of a heterodimer complex and then activates the transcription of other clock genes (e.g., PER, CRY, and REV-ERBα) by integrating with cis-acting element E-box [9, 10]. After entering the nucleus, the transcriptional complex of PER and CRY produces a negative feedback loop to repress CLOCK/BMAL1 activity. PER and CRY are subsequently inhibited, while the PER/CRY repressor complex is reduced as CLOCK/BMAL1 concentrations are decreased [9, 10]. The nuclear receptors of REV-ERBα and RORα are regulated by the CLOCK/BMAL1 complex, while REV-ERBα inhibits BMAL1 transcription and RORα induces it [10, 37] (Fig. 2). Therefore, the main circadian clock genes are continuously activated with another cycle begins, and this auto-regulation feedback loop occurs approximately every 24-h [10, 38].

Figure 2.

Figure 2.

Molecular mechanism of circadian clock. After cues from Zeitgebers of light, temperature, eating, or drinking are perceived and transmitted to SCN as electrical signals, the central circadian clock system synchronizes with geophysical time and feedbacks to the downstream brain regions and periphery via nervous system and hormone release. Briefly, CLOCK and BMAL1 form the core transcription factor of a heterodimer complex and then activates the transcription of other clock genes (like PER, CRY, and REV-ERBα) by integrating with cis-acting element E-box. After entering nucleus, the transcriptional complex of PER and CRY produces a negative feedback loop to repress CLOCK/BMAL1 activity; the PER and CRY are subsequently inhibited while PER/CRY repressor complex also reduced as CLOCK/BMAL1 concentration is decreased. The nuclear receptors of REV-ERBα and RORα are regulated by CLOCK/BMAL1 complex, while REV-ERBα also inhibits BMAL1 transcription but RORα induces it. Thus, the main circadian clock genes are continuously activated by the last with another cycle begins, this auto-regulation feedback loop happens about 24-h.

Mechanisms of erectile function

Penile erection is a complex neurovascular process, which involves the nervous and endocrine system, as well as endothelial and smooth muscle cells (SMCs) in sinusoids and vessels [39, 40]. The tumescent/erectile or detumescent/flaccid status of the penis is determined by the balance between contractive and relaxant factors [40], and it routinely maintains a flaccid condition with contracted SMCs.

Under sexual stimulation, nitric oxide (NO) is released from nonadrenergic noncholinergic nerve fibers and endothelial cells [14, 18]. NO then diffuses across the smooth muscle membrane to activate guanylate cyclase, which induces protein kinase G (PKG) by increasing cyclic guanosine monophosphate (cGMP) levels. This alteration then decreases cytosolic calcium (Ca2+) levels by changing ion channel permeability and finally causes vasodilation of the smooth muscle in the corpora cavernosa [14, 41, 42]. The blood then fills the corpora cavernosa and blocks venous outflow (veno-occlusion) by compressing subcutaneous venules [18]. Therefore, intact endothelial cells and SMCs are fundamental factors for a normal erection. However, the mechanism of ED is complex with diverse risks [14, 18, 43]. With regard to nonendocrine reasons for ED, vasculogenic which affects arterial inflow or venous outflow is the most common (>80% of all cases), others include neurogenic (affecting innervation and nervous function) and iatrogenic (relating to medical or surgical treatment) factors [18]. With regard to endocrine etiologies, reduced serum testosterone levels have been well clarified [18], while the possibility of melatonin is being explored [44].

Circadian clock and ED

As the main zeitgeber, light is the fundamental synchronization factor that regulates the 24-h circadian cycle [4, 29, 30]. Sleep and wakefulness also tightly co-regulate the circadian clock and the sleep-wake homeostatic process. Therefore, a good sleep rhythm is essential for human health [45]. However, routine behavioral patterns have dramatically altered the day-night rhythm over the past decades [46]. Accumulating evidence has also shown that circadian sleep disorders, disrupted sleep, and insufficient sleep are closely correlated to diverse disease [9-12], including male ED [11, 20, 45] (Fig. 1).

A circadian sleep disorder is defined as an inability to sleep at the desired time rather than sleep generating dysfunction, such as staying up at night for work but sleeping at daytime (shift work disorder) or rapidly traveling to new time zones (jet lag or time zone change syndrome) [45]. For instance, shift work is prevalent worldwide which comprising more than 15% of the workforce [11, 20, 45, 47]. Additionally, up to 50% of some professions, such as police, firefighters, transport drivers, manufacturing employees, and hospital workers, have shift work [45]. An altered sleep-wake cycle inevitably disturbs the internal circadian clock and impairs metabolic homeostasis [5, 8, 9]. These shift workers are likely to feel fatigue, have a lack of energy, and be vulnerable to disease. Meanwhile, they are also unwilling or unable to achieve satisfactory sexual function, especially after shift work at night [5, 45, 48]. Pastuszak et al. studied 182 men and found that nonstandard shift workers had a lower international index of erectile function (IIEF) score, including lower sexual desire, erectile and orgasmic function, as well as intercourse and overall satisfaction [48, 49]. Katherine et al. recruited 745 men and showed the night shift workers showed 7.6 points lower IIEF-EF scores than those worked during the day or evening (P<0.01), while nonstandard shift workers with shift work sleep disorder had lower IIEF-EF (2.8 points) than those without (P<0.01) [11, 20].

As the most important disrupted sleep [26], obstructive sleep apnea (OSA) is defined as partial or complete collapse of the upper airway, and is characterized by loud snoring and absent airflow [45]. It is a common disease with an incidence of 4.0%-32.8% for middle age and 22.4% for older than 60 years [45]. In 1981, Guilleminault et al. initially reported that 48% men with severe OSA suffered from ED [25]. Numerous studies then reported that OSA had a fairly high ED rate (range: 47.1%-80.0%) [45, 50-52] and its severity was correlated with ED development [45, 53]. Additionally, continuous positive airway pressure (CPAP), which is an essential treatment of OSA, significantly improves erectile function [26, 54].

Insufficient sleep is another common sleep disorder that is mainly caused by work schedules and environmental factors like noise and light population [26]. The National Sleep Foundation has recommended a sleep duration of 7-9 h for individuals aged 18-64 years and 7-8 h for those older than 65 years [26, 55]. However, the National Health Interview Survey showed that 30% of workers (approximately 40.6 million) reported an average sleep duration of <6 h in the United States [56]. Insufficient sleep (<5 h) also indicates a lower sexual activity (odds ratio [OR]: 0.88, 95% confidence interval [CI]: 0.80-0.96) and less sexual satisfaction (OR: 0.88, 95% CI: 0.81-0.95), which are improved by extended sleep on the following day [57]. An additional hour of sleep elevates satisfaction in sexual activity by 14% [57].

Although numerous studies have shown that a disturbed sleep rhythm can impair erectile function, the endogenous mechanism has not been clarified. Furthermore, whether and how the circadian clock is involved in erectile dysfunction require further investigation [11, 45].

Associations between the circadian clock and ED

Impaired NO/cGMP pathway

As shown previously, NO released from the nerves (nNOS) or endothelium (eNOS) nitric oxide synthase is the primary and indispensable neurotransmitter in penile erection [43], while nNOS initiates penile erection and eNOS maintains or enhances it [40]. The impaired NO production inevitably leads to vasculogenic ED [40]. Actually, old rats with ED always have a lower amount of NOS-containing nerves, as well as decreased NOS mRNA expression and NOS activity [40, 58]. Our previous study also showed that aging rats had lower intracavernous pressure (ICP) and eNOS expression in the corpus cavernosum [59]. Additionally, rats with diabetes or bilateral cavernous nerve crush (BCNC) induced ED showed lower nNOS or eNOS expression and activity, as well as impaired NO production in the corpus cavernosum [39, 40, 60, 61].

The NO/cGMP controlled human forearm blood flow has a peak value at 8 a.m. and a nadir at 8 p.m. [62, 63], this rhythm is also found in the rat aorta and mesenteric arteries [62, 64]. In Bmal1 knockout mice, superoxide inhibits NO release by suppressing eNOS activation. This inhibition is reversed by scavenging reactive oxygen species (ROS) with PEG-SOD or a non-selective cyclooxygenase inhibitor like indomethacin [9, 65]. The phenylephrine-induced contractile rhythm in the mesenteric artery is abolished in endothelial-specific Bmal1 knockout [62, 66]. Per2 mutation mice show decreased NO and vasodilatory prostaglandin production, and enhanced release of vasoconstrictive agents [9, 67]. Insulin-stimulated NO release is also compromised by Per2 mutation in active and inactive phases [23, 68].

Oxygen is an essential substrate in the NO pathway [25, 69]. Hypoxia impairs eNOS expression and decreases NO concentrations by promoting ROS production (e.g., superoxide, peroxynitrite, and hydrogen peroxide), which finally deteriorates erectile function [19, 25, 69]. For instance, superoxide and peroxynitrite decrease NO concentrations by inducing endothelial cell apoptosis [19, 70, 71], superoxide also reduces NO levels by reacting with it to produce peroxynitrite [19, 71]. Meanwhile, hypoxia promotes vasoconstriction, NO reduction, endothelial dysfunction, and turbulence in the hypothalamic-pituitary-gonadal axis by increasing oxidative stress and sympathetic activity [25]. Because OSA causes intermittent hypoxia, some authors speculate that this circadian disorder impairs erectile function by decreasing NO production, changing sex hormones, and leading to neurological dysfunction [19, 25, 72]. Hypoxia also damages erectile function by inducing vasoconstrictors of endothelin, while CPAP preserves it by attenuating hypoxemia and inhibiting endothelin production in patients with OSA [19, 73]. Lee et al. found that rats in the sleep-deprived group (0.404±0.031) had a significantly lower ICP/MAP ratio than the control (0.718±0.030) and testosterone supplementation (0.55±0.030) groups. Additionally, lower nNOS and eNOS (both mRNA and protein levels) were observed in the sleep-deprived group [11, 74].

Taken together, these studies indicate that the NO/cGMP signal is regulated by circadian variation [62, 63]. However, how the circadian clock affects penile erection and how the NO/cGMP pathway is involved remain to be clarified.

Endothelial Dysfunction

The penis is a highly vascularized organ, and therefore, penile erection is dependent on the intact endothelial structure of the corpus cavernosum [22]. Briefly, the endothelial bed maintains the erectile process by regulating vascular and smooth muscle vasodilative tone, maintaining vascular pressure, inhibiting thrombosis, and inducing fibrinolysis [75]. Endothelial dysfunction, mainly caused by reduced or absent eNOS-NO bioactivity or bioavailability in the vasculature [75], is defined as decreased responsiveness to vasodilators or increased sensitivity to vasoconstrictors [22, 76]. The endothelial dysfunction is also involved in the circadian clock [23, 62].

Bmal1 or Per2 mutation significantly decreases endothelium dependent relaxation of aortic rings [9, 67, 77, 78]. Bmal1 knockout mice show damaged aortic endothelial function because elevated superoxide concentrations reduce NO production by inhibiting eNOS activation [9, 78]. Bmal1 knockout or Clock mutant mice show endothelial dysfunction and vascular injury by impairing Akt and subsequent NO signaling [9, 77]. In Per2 mutation mice, endothelium dependent relaxation to acetylcholine in aortic rings is impaired, while transformation of the relaxation response from the inactive to the active phase is decreased in Per2 mutants, but increased in wild-type littermates [23, 79].

The impaired barrier function, inflammatory response, adhesion molecule expression, and leukocyte migration also contribute to endothelial dysfunction [9, 23, 43, 79, 80]. Genetic Bmal1 ablation impairs endothelial integrity and barrier function, and promotes expression of chemokines C-C motif ligand (Ccl)8/20 and chemokine (C-X-C motif) ligand (Cxcl)5 [23, 81]. Clock promotes intercellular adhesion molecule-1 expression or monocyte adhesion to endothelial cells [23, 82]. By binding to E-box-like enhancer, Clock upregulates intercellular adhesion molecule 1 (ICAM-1) expression to promote mononuclear cells adhere to endothelial cells [9, 82]. Meanwhile, sleep-deprived mice show increased pro-inflammatory cytokine expression and decreased CRY1 in vascular endothelial cells. These effects are reversed by the nuclear factor-κB (NF-κB) and cyclic adenosine monophosphate /protein kinase A (cAMP/PKA) pathways after Cry1 overexpression [23, 83].

The circadian clock also regulates endothelial function by hypercoagulability [9, 23]. The photochemical injured model has shown a diurnal variation in the time of thrombotic vascular occlusion (TTVO), that the TTVO is two-folds higher in the resting phase (zeitgeber time [ZT] 4-8; ZT 0: lights on, ZT 12: lights off) than in the active period (ZT 12-20). This oscillation is disrupted when Clock, Bmal1, or Npas2 is deleted or mutated [9, 84]. Bmal1 regulates the expression of fibrinogen, von Williebrand factor (vWF), and prothrombotic factors plasminogen activator inhibitor (PAI)-1 in aortic endothelial cells [9, 78]. The integral membrane glycoprotein of thrombomodulin, which is essential in regulating intravascular coagulation, also shows a circadian rhythm, while the Clock:Bmal2 heterodimer elevates its expression by binding to enhance element [9, 85].

Endothelial function is damaged by a disturbed circadian rhythm. But how circadian disorders promote endothelial dysfunction, except for involvement of the NO/cGMP pathway, also needs to be determined.

Dysfunction of SMCs

Although with normal NO release, a penile erection is absent when the abundance, composition, or regulation of SMCs is altered [22, 86, 87]. Therefore, contraction and relaxation of SMCs in the corpus cavernosum are other central molecular mechanisms of a penile erection [22, 88]. For corpus cavernosum in diabetic ED rat, the maximum SMC contraction in response to phenylephrine is reduced by 50% [22, 89]. Additionally, in vitro relaxation of corporal tissue from the penile dorsal artery and the SMC/collagen ratio are reduced, and apoptosis is increased in diabetic rats with ED [22, 90]. Meanwhile, mRNA levels of smooth muscle alpha-actin and differentiated smooth muscle (e.g., smooth muscle myosin heavy chain, smoothelin, calponin, and myocardin) in the corpus cavernosum are also dramatically inhibited [22, 87].

Numerous studies have reported that SMCs are controlled by the circadian clock [9, 23]. In vascular SMCs (VSMCs) of carotid arteries from healthy humans, mRNA expressions of BMAL1, PER1/2/3, and CRY1/2 shows a circadian rhythm. However, this oscillation is attenuated in plaque-derived VSMCs [23, 91]. SMC-specific Bmal1 knockout mice show decreased blood pressure and compromised circadian rhythm as the vessel contractility is impaired and the arterial lumen diameter is increased. Furthermore, the time-of-day variations in response to agonist-induced vasoconstriction, ROCK2 activation, and myosin phosphorylation are also abolished in mesenteric arteries [23, 92]. In db/bd mice, 24-h mRNA rhythms of Per1/2 and Cry1/2 in the aortic and mesenteric arteries, Per1 and Rev-erba in the kidney, and Per1 in the SCN are significantly suppressed. The contraction-related proteins like Rho kinase 1/2, calponin-3, tropomyosin-1/2, smooth muscle protein 22-α, and PKC-potentiated phosphatase inhibitory protein of 17 kDa are also inhibited [9, 93]. Additionally, 24-h aortic contractile variations in response to phenylephrine (α1-agonist), angiotensin II, and high K+ levels are all significantly altered [9, 93]. For VSMCs of thoracic aorta from mice with high-fat diet, Smarcd1 promotes Bmal1 transcription by directly stimulating and co-activating nuclear RORα [9, 94]. Moreover, expression of tissue inhibitor of metalloproteinase 1/3 (timp1/3), collagen 3a1 (col3a1), calponin 1 (cnn1), and transgelin 1 (sm22alpha) in the immortalized VSMC line Movas-1 also shows a circadian pattern [9, 95].

Regardless of the information provided by these studies, how the circadian clock regulates penile erection by manipulating SMC function is unknown. Furthermore, whether a normal circadian rhythm can reverse impaired endothelial cells or SMCs needs to be investigated.

Atherosclerosis

ED is mainly regarded as an organic vascular disorder [21, 22]. Atherosclerosis, which is an inflammatory disease with leukocyte accumulation [9] and characterized by fatty deposition in arterial inner wall [23], leads to vasculogenic ED [40] by decreasing penile blood flow [96]. As sharing similar risk factors, numerous studies treated ED as a preceded marker of vascular disease to predict cardiovascular disease (CVD) [40, 97, 98]; it is also strongly related to the severity of coronary lesions [22, 97]. For instance, Montorsi et al. found that the incidence of ED was 49% in 300 men with angiographically confirmed coronary artery disease, while 67% of them suffered from ED before coronary artery disease symptoms [22, 99]. A rabbit model with atherosclerotic vascular disease showed that ED incidence was 93% in those with >50% luminal occlusion in the iliohypogastric arteries, while it was only 33% in those with minimal lesions [100, 101]. One explanation for this finding is the arterial size hypothesis, which states that larger coronary vessels can adapt to more narrowing and plaque deposition without obviously reduced blood flow. However, the small cavernosal diameter (<1-2 mm) was more difficult to sustain sufficient blood flow for penile erection, even with minimal luminal narrowing [22].

The Nurses’ Health Study cohort showed that women with 6 years or more of rotating shift work were 1.51 (95% CI: 1.12-2.03) times more likely to develop CVD [24, 102]. Another study found the non-standard shift workers had a 40% higher risk of developing atherosclerosis or CVD than their daytime colleagues [11, 49]. OSA can initiate and accelerate CVD development [25], while sleep disturbance induces arterial atherosclerotic plaques and promotes endothelial dysfunction by inducing inflammation and inflammatory mediators [96, 103, 104]. Moreover, a short sleep duration, poor sleep, and insomnia all lead to CVD by increasing the atherosclerotic risk [96, 105].

Vascular function has a circadian rhythm in healthy mouse aorta [9], as shown by a peak in Bmal1 expression during the dark phase and a peak in Per1/2 expression during rest [9, 106]. Disrupted rhythms promote atherosclerotic progression [23] by mediating cardiovascular complications, such as stenotic atherosclerotic lesions, diabetic vasculopathies, senescence, graft failure, and pathological vascular remodeling [9, 46]. Cholesterol ester transfer protein (CETP) mice with a 12-h light-dark shift cycle for 15 weeks show a higher incidence of atherosclerosis [46]. Dominant-negative Clock mutant apolipoprotein E (Apoe)-/- mice reveal increased atherosclerosis by enhancing intestinal cholesterol absorption, promoting modified lipoprotein uptake, and decreasing cholesterol efflux from macrophages [9, 107]. In low density lipoprotein receptor (Ldlr)-/- and Apoe-/- mice, Clock knockout induces more atherosclerotic lesions at the aortic arches and aortic root [23, 107], but this progress is reduced by upregulated Cry1 expression [23, 108] or REV-ERBβ agonist delivery [23, 109].

Bmal1 ablation mice have significantly thickened arterial walls with increased collagen deposition in the medial layer [46, 110]. Accelerated arterial thrombus formation has been found as shown by enhanced von Willebrand factor (vWF), fibrinogen, and plasminogen activation inhibitor-1 (PAI-1) production [46, 111]. Bmal1 downregulation promotes oxidative stress and this aggravates periodontitis-related atherosclerosis induced by Porphyromonas gingivalis [10, 112]. Moreover, aortic grafts from wild-type mice are normal when inserted into Bmal1-/- or Per1/2-/- mice. However, aortic grafts from Bmal1-/- or Per1/2-/- mice show robust arteriosclerotic disease when transplanted into wild-type mice [9, 113].

CRY1 mRNA expression is significantly lower in patients with atherosclerosis, while augmented CRY1 expression reverses the atherosclerotic process by the Toll-like receptor (TLR)/nuclear factor kappa-B (NF-κB) pathway [9, 108]. In hematopoietic cells in Ldlr null mice, decreased Rev-erbα expression promotes atherosclerosis, which is suppressed by a synthetic REV-ERB agonist (SR9009) [9, 109]. In Ldlr-/- mice, Rev-erbα knockdown in bone marrow cells increases atherosclerotic lesions around aortic valves. Additionally, inflammatory M1 macrophages are decreased and M2 macrophage markers are increased when Rev-erbα is overexpressed in these mice [9, 114].

Taken together, these studies suggest that the circadian clock independently regulates arteriosclerotic disease [9, 113, 114]. However, further clinical and fundamental research is warranted to better clarify the internal molecular pathways in the process of ED.

Diabetes mellitus

The Massachusetts Male Aging Study showed that men with diabetes had a higher incidence of ED than the general population (28% vs. 9.6%) [40, 115]. Other studies showed that these patients suffered from a 75% lifetime risk of ED and earlier onset than individuals without diabetes [40, 116]. Diabetes mellitus (DM) is the main risk factor for ED [40, 116, 117] because hyperglycemia has systemic effects to impair vasodilatory signaling, and leads to SMC hyper-contractility and veno-occlusive disorder [40, 118, 119]. Diabetes or chronic elevated glucose concentrations decrease NO production by damaging penile nNOS content and activity [40, 120]. This is achieved by inducing the formation of reactive oxygen species (ROS), reactive nitrogen species (RNS) [75], and advanced glycation end products (AGEs) [40, 121]. Glycosylated human hemoglobin impairs smooth muscle relaxation by generating superoxide anions and activating extracellular NO [40, 122], while insulin resistance alters the vascular response to vasoconstriction rather than vasodilation [97]. Furthermore, DM decreases endothelium-dependent vasorelaxation by activating protein kinase C (PCK), impairing cholesterol biosynthesis [22, 123, 124], inhibiting peroxisome proliferator-activated receptor-γ, and increasing the oxidative stress state [22, 89, 125]. All of these factors finally lead to ED [40].

The secretion and sensitivity of insulin display obvious diurnal rhythms [23, 126]. Glucose tolerance is higher in the morning than the evening/night for healthy humans [23, 127], but this rhythm is absent in patients with T2DM because of impaired circadian oscillation of glycometabolism [23, 128]. A comprehensive study of 788 healthy people showed a U-shaped relationship between sleep duration and insulin resistance in which both a long and short sleep duration induced resistance [26, 129]. Five randomized studies indicated that insulin resistance increased by 15%-25% when sleep was restricted for 1, 4, 5, and 14 days [26]. However, this risk was reduced when shift workers improved their sleep duration or had a suitable circadian lifestyle [23, 130]. Indeed, people who experienced social jet lag [26] or shift work [5, 26, 131] suffered from more metabolic diseases such as T2DM and obesity. A prospective study that enrolled 402 nightshift workers and 336 daytime workers showed that nightshift workers had a five-fold higher risk of developing T2DM or obesity after follow up for 4 years [24, 132]. Another meta-analysis that included 34 studies (>2 million individuals) showed that shift workers were associated with higher rates of T2DM and vascular events than non-shift workers [26, 133]. Additionally, circadian rhythm impairment induces insulin resistance in as little as 1 day [26]. This risk increases from 14% to 26% with 1, 2, 3, and 4 days of circadian rhythm impairment, while it is elevated to 55% when combined with sleep restriction [26]. Mice that are exposed to constant 24-h bright light show weight gain and glucose intolerance compared with those with a normal light-dark cycle, although caloric intake is not increased [134].

Numerous fundamental studies have attempted to clarify the relationship between circadian disorders and DM [23]. Impaired glucose tolerance, inhibited insulin secretion, and reduced pancreatic islet proliferation are found in Clock [135] or Bmal1 [136] mutant mice. Clock and Bmal1 mutant mice also develop diabetes by impairing insulin secretion [137]. Clock mutation mice have impaired hepatic glycogen oscillation and altered circadian mRNA and protein expression of glycogen synthase 2 (Gys2) (limiting enzyme of glycogenesis) [138]. Damaged glucose tolerance, increased plasma glucose levels, and decreased insulin secretion are found in pancreas- or β-cell-specific Bmal1 knockout mice [23]. Bmal1 ablation mice are prone to developing insulin resistance and an obesity phenotype by an alteration in glucose metabolism and impaired insulin signaling [139]. Moreover, Per2 repression decreases plasma glucose levels, stimulates insulin secretion, and impairs gluconeogenesis [140]. A lack of Cry1/2 induces glucose intolerance and increases circulating corticosterone levels, suggesting that the hypothalamic-pituitary-adrenal axis may be stimulated and glucocorticoid transactivation is increased [141]. Rev-erbα mutant mice with chow diet have increased adiposity (2.5-fold) and mild hyperglycemia (approximately 10%) without insulin resistance [142]. This finding may be explained by REV-ERBα affecting plasma glucose homeostasis by regulating glucose-6-phosphatase and phosphoenol-pyruvate carboxylase [23].

In a word, these findings suggest that the circadian clock regulates glycometabolism by key enzymes of glycometabolism [23, 143]. However, how DM affects circadian disorder and ED is still unclear.

Lipid abnormalities

Lipid abnormalities, such as decreased high-density lipoprotein (HDL) levels, and increased low-density lipoprotein (LDL) or total cholesterol levels, are well known risk factors for atherosclerosis and endothelial dysfunction, which also finally contribute to ED [100]. The Massachusetts Male Aging Study [100, 115] also showed that low HDL levels were the best predictor of ED. In this study, the incidence of moderate ED increased from 6.7% to 25% for men aged 40 to 55 years, and the incidence of complete ED increased from 0% to 16% in those aged 56 to 70 years when HDL levels decreased from 90 mg/dL to 30 mg/dL [100, 115], while per mmol/L elevated HDL levels indicated a lower risk of ED (0.38 times the risk of ED; 95% CI: 0.18-0.80) [100, 144]. Dietary cholesterol consumption also significantly promoted ED (OR: 1.27, P=0.06), which was marginally reduced by unsaturated fat intake (OR: 0.92, P=0.05) [100, 145]. Lipid abnormalities may reduce endothelium-dependent SMC relaxation in the corpus cavernosum rather than neurogenic-dependent [40, 100, 146]. In hypercholesterolemic animals, endothelium-dependent relaxation is improved with L-arginine, which suggests that a lack of L-arginine causes NO deficiency, but not impaired NOS activity [40, 146].

The circadian clock also has complicated roles in lipid metabolism. Normal circulating lipids show circadian oscillations within a narrow physiological range [9, 23] independent of food intake [23], with peak plasma HDL levels occur in the early rest period and then decrease in the active phase [23, 147]. In ad libitum-fed rats/mice with a 12-h photoperiod, plasma cholesterol and triglyceride levels are high in the night owing to a fluctuation in apolipoprotein B lipoprotein levels [9, 148]. Intestinal lipoprotein production shows diurnal variation as absorption of [(3)H]-triolein and [(3)H]-cholesterol is higher at 2400 h than at 1200 h [9]. Protein, mRNA, and activity of microsomal triglyceride transfer protein (MTP) in the intestine and the liver show diurnal variability, which are completely abolished with extended exposure to light or dark [9, 148]. In the liver of ad libtum-fed animals, regulators of cholesterol and triglycerides (e.g., sterol regulatory element-binding protein (SREBP)-1c, acetyl co-A carboxylase [ACC], fatty acid synthase [FAS], acetyl-CoA synthase [ACS], 3-hydroxy-3-methylglutaryl-coenzyme A [HMG CoA], and glycerol-3-phosphate acyltranferase [GPAT]) show circadian cycles [9]. In children, a reduced sleep duration increases the risk of overweight [23, 149], while an unhealthy lifestyle or poor sleep is associated with hyperlipidemia and obesity with age [23, 150]. All these studies suggest that circadian rhythms regulate lipid metabolism [23, 151] and that circadian disorders lead to lipid abnormalities [23].

In humans with obesity, 24-h gene expression of CLOCK, BMAL1, PER1, CRY2, and REV-ERBα in adipocytes is disturbed. Additionally, CLOCK expression is related to LDL levels, RORα is correlated with HDL levels, and REV-ERBα is associated with waist circumference and body mass index (BMI) [23, 152]. Enterocytes in Clock mutant mice show increased cholesterol levels, which are absorbed from the intestinal lumen, as well as secretion of chylomicrons and cholesterol [23, 107]. Homozygous Clock mutant mice have a significantly attenuated diurnal feeding rhythm, and they develop metabolic syndromes of hyperlipidemia, hyperglycemia, hypoinsulinemia, and hepatic steatosis [9, 135]. Global- or liver-specific Bmal1 ablation Apoe-/- mice have higher risks of hyperlipidemia and atherosclerosis, which are reversed by virus-mediated Bmal1 overexpression [23, 153]. Another study also showed that liver-specific Bmal1 or Rev-erbα knockout increased circulating levels of cholesterol, triglycerides, and free fatty acids by accumulating oxidative damage [9, 154, 155]. However, these metabolic outcomes were improved by restoration of hepatic Bmal1 activity in high fat-fed mice [9, 154]. Bmal1 knockout increases levels of cholesterol, triglycerides, and free fatty acids by reducing the fat storage capacity in adipose tissue, which finally promotes ectopic fat formation in the liver and skeletal muscle [5, 156]. PER2 regulates expression of PPARγ and PPARγ target genes to control adipogenesis and lipid metabolism [5]. Per2 knockout mice show an altered lipid profile and greatly reduced triacylglycerol levels, while fibroblast-specific Per2 deletion show enhanced adipocyte differentiation [5, 157, 158]. Per1/2/3 knockout mice are more likely to have obesity, which suggests that it regulates body weight [5, 159]. Liver CYP7A1, which is transcriptionally regulated by the circadian oscillator of NR1D1, promotes cholesterol converse to bile acids, while sleep disturbance accelerates serum and liver cholesterol accumulation by inducing NR1D1-mediated CYP7A1 inhibition [160]. Finally, Rev-erbα deletion increases plasma lipid levels, and decreases hepatic cholesterol and triglyceride levels by inducing Insig2 expression [9, 161], while dual depletion of Rev-erbα and Rev-erbβ function greatly disrupt circadian clock expression and deregulate lipid metabolism [9, 28].

Owing to complex interactions, whether and how the circadian clock regulates ED through lipid metabolism are unclear. Therefore, further studies on this issue are required.

Testosterone deficiency

Circulating androgen levels are essential for penile maturation and development [22, 162, 163]. Androgen is also necessary in penile erection by regulating the NO/cGMP pathway, activating arterial flow, relaxing corporal smooth muscle, and manipulating veno-occlusion [22, 40]. Penile constitutive NOS activity is impaired in rats with castration or antiandrogen flutamide [22, 40]. Low testosterone levels alter endothelial morphology, change corporal smooth muscle, decrease elastic fibers in the tunica albuginea, and promote extracellular matrix deposition [22, 164, 165]. In older men [22, 166, 167] or patients receiving androgen suppression [22, 166], ED is common as a reduced amount of smooth muscle and increased collagen deposition. However, supplemental testosterone therapy preserves erectile function by reversing corporal structural changes [22, 168, 169], preventing degeneration, and preventing against oxidative damage [11, 74]. Testosterone also decreases visceral obesity and improves the responsive ability to PDE5i [22, 170].

Normal testosterone release has a circadian rhythm, which starts to rise at sleep onset and reaches a peak during the first rapid eye movement (REM) sleep bout [45, 171]. However, this fluctuation is impaired by circadian disruption, such as sleep disturbance and abnormalities of sleep quality or duration [96, 172, 173]. Decreased testosterone levels have been found in patients with insomnia or insufficient sleep [45]. Serum testosterone levels are greatly reduced when sleep is restricted to 5-h per night for 8 nights [45, 174], while salivary testosterone levels decline with acute sleep loss for 33-h [45, 175]. Axelsson et al. studied 42 shift workers and found that dissatisfied staff had lower morning testosterone levels compared with satisfied staff [176, 177]. However, lower testosterone levels were associated with more severe disturbed sleep/wakefulness, greater lack of sleep, and an increased need for recovery after work [176, 177]. Additionally, an increased need for recovery after work was the best predictor of testosterone levels [176, 177]. A study on a 5-day military endurance training course with sleep for 1-3 h showed that testosterone, free testosterone, dehydroepiandrosterone, 17 alpha-hydroxyprogesterone, and androstenedione levels were decreased by 60%-80% [176, 178]. Rats with sleep deprivation for 24-48 h showed reduced serum testosterone levels as a result of 5-HT-related inhibition of testosterone production and reduced testicular StAR protein expression [179].

In summary, the effect of testosterone on erectile function and the circadian clock on testosterone is clear. However, whether and how circadian disruption impairs erectile function by regulating testosterone is unknown, and further research is required.

Conclusion

Convincing evidence shows that a disturbed circadian clock due to shift work, irregular sleep-wake cycle, or inappropriate modern lifestyle impairs human health and contributes to various diseases, including ED. Accumulated research has also shown that the circadian rhythm is important in affecting several risk factors of ED, such as the NO/cGMP pathway, atherosclerosis, DM, lipid abnormalities, testosterone deficiency, and dysfunction of endothelial and SMCs. However, the mechanism of how the circadian clock regulates erectile function remains elusive, and which specific clock genes are involved in ED also requires further research. There is much to learn about the circadian clock to recommend a healthier lifestyle and a more regular sleep rhythm or duration in humans. This information may provide novel preventative measures and therapeutic targets to reduce the process of ED, and to finally promote sexual satisfaction for men and their partners.

Acknowledgments

This manuscript was funded by National Nature Science Foundation of China (No. 82060276 and 82060462) and The Science and Technology Department of Guizhou Province (QianKeHeJiChu-ZK 2021, YiBan382).

Footnotes

Competing interest statement

The authors declare no competing interests.

References

  • [1].Shibata S, Tahara Y, Hirao A (2010). The adjustment and manipulation of biological rhythms by light, nutrition, and abused drugs. Adv Drug Deliv Rev, 62:918-927. [DOI] [PubMed] [Google Scholar]
  • [2].Bass J, Takahashi JS (2010). Circadian integration of metabolism and energetics. Science, 330:1349-1354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Mohawk JA, Green CB, Takahashi JS (2012). Central and peripheral circadian clocks in mammals. Annu Rev Neurosci, 35:445-462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Chan MC, Spieth PM, Quinn K, Parotto M, Zhang H, Slutsky AS (2012). Circadian rhythms: from basic mechanisms to the intensive care unit. Crit Care Med, 40:246-253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Fatima N, Rana S (2020). Metabolic implications of circadian disruption. Pflugers Arch, 472:513-526. [DOI] [PubMed] [Google Scholar]
  • [6].Goel N, Basner M, Rao H, Dinges DF (2013). Circadian rhythms, sleep deprivation, and human performance. Prog Mol Biol Transl Sci, 119:155-190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Manoogian ENC, Panda S (2017). Circadian rhythms, time-restricted feeding, and healthy aging. Ageing Res Rev, 39:59-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Panda S (2016). Circadian physiology of metabolism. Science, 354:1008-1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].McAlpine CS, Swirski FK (2016). Circadian Influence on Metabolism and Inflammation in Atherosclerosis. Circ Res, 119:131-141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Xu H, Huang L, Zhao J, Chen S, Liu J, Li G (2020). The circadian clock and inflammation: A new insight. Clin Chim Acta, 512:12-17. [DOI] [PubMed] [Google Scholar]
  • [11].Vignozzi L, Maggi M (2020). Circadian rhythm and erectile function: is there a penile clock? Nat Rev Urol. [DOI] [PubMed] [Google Scholar]
  • [12].Masri S, Sassone-Corsi P (2018). The emerging link between cancer, metabolism, and circadian rhythms. Nat Med, 24:1795-1803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Tobaldini E, Costantino G, Solbiati M, Cogliati C, Kara T, Nobili L, et al. (2017). Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neurosci Biobehav Rev, 74:321-329. [DOI] [PubMed] [Google Scholar]
  • [14].Fazio L, Brock G (2004). Erectile dysfunction: management update. CMAJ, 170:1429-1437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Bohm M, Baumhakel M, Probstfield JL, Schmieder R, Yusuf S, Zhao F, et al. (2007). Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND). Am Heart J, 154:94-101. [DOI] [PubMed] [Google Scholar]
  • [16].Gleason JM, Slezak JM, Jung H, Reynolds K, Van den Eeden SK, Haque R, et al. (2011). Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction. J Urol, 185:1388-1393. [DOI] [PubMed] [Google Scholar]
  • [17].Frederick LR, Cakir OO, Arora H, Helfand BT, McVary KT (2014). Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients. J Sex Med, 11:2546-2553. [DOI] [PubMed] [Google Scholar]
  • [18].Yafi FA, Jenkins L, Albersen M, Corona G, Isidori AM, Goldfarb S, et al. (2016). Erectile dysfunction. Nat Rev Dis Primers, 2:16003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Jankowski JT, Seftel AD, Strohl KP (2008). Erectile dysfunction and sleep related disorders. J Urol, 179:837-841. [DOI] [PubMed] [Google Scholar]
  • [20].Rodriguez KM, Kohn TP, Kohn JR, Sigalos JT, Kirby EW, Pickett SM, et al. (2020). Shift Work Sleep Disorder and Night Shift Work Significantly Impair Erectile Function. [J] Sex Med. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V (2004). Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res, 16:350-353. [DOI] [PubMed] [Google Scholar]
  • [22].Musicki B, Bella AJ, Bivalacqua TJ, Davies KP, DiSanto ME, Gonzalez-Cadavid NF, et al. (2015). Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction. J Sex Med, 12:2233-2255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Zhang Z, Yu B, Wang X, Luo C, Zhou T, Zheng X, et al. (2020). Circadian rhythm and atherosclerosis (Review). Exp Ther Med, 20:96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Otamas A, Grant PJ, Ajjan RA (2020). Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection. Diab Vasc Dis Res, 17:1479164120920582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Kalejaiye O RA, Moubasher A, Capece M, McNeillis S, Muneer A, Christopher AN, Garaffa G, Ralph DJ (2017). Sleep disorders in patients with erectile dysfunction. BJU Int, 120:855-860. [DOI] [PubMed] [Google Scholar]
  • [26].Liu PY (2019). A Clinical Perspective of Sleep and Andrological Health: Assessment, Treatment Considerations and Future Research. [J] Clin Endocrinol Metab. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Lucas RJ, Freedman MS, Lupi D, Munoz M, David-Gray ZK, Foster RG (2001). Identifying the photoreceptive inputs to the mammalian circadian system using transgenic and retinally degenerate mice. Behav Brain Res, 125:97-102. [DOI] [PubMed] [Google Scholar]
  • [28].Nguyen KD, Fentress SJ, Qiu Y, Yun K, Cox JS, Chawla A (2013). Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes. Science, 341:1483-1488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Dibner C, Schibler U, Albrecht U (2010). The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol, 72:517-549. [DOI] [PubMed] [Google Scholar]
  • [30].Golombek DA, Rosenstein RE (2010). Physiology of circadian entrainment. Physiol Rev, 90:1063-1102. [DOI] [PubMed] [Google Scholar]
  • [31].Balsalobre A, Damiola F, Schibler U (1998). A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell, 93:929-937. [DOI] [PubMed] [Google Scholar]
  • [32].Duguay D, Cermakian N (2009). The crosstalk between physiology and circadian clock proteins. Chronobiol Int, 26:1479-1513. [DOI] [PubMed] [Google Scholar]
  • [33].Teboul M, Gréchez-Cassiau A, Guillaumond F, Delaunay F (2009). How nuclear receptors tell time. J Appl Physiol (1985), 107:1965-1971. [DOI] [PubMed] [Google Scholar]
  • [34].Cuninkova L, Brown SA (2008). Peripheral circadian oscillators: interesting mechanisms and powerful tools. Ann N Y Acad Sci, 1129:358-370. [DOI] [PubMed] [Google Scholar]
  • [35].Duffield GE (2003). DNA microarray analyses of circadian timing: the genomic basis of biological time. J Neuroendocrinol, 15:991-1002. [DOI] [PubMed] [Google Scholar]
  • [36].Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H (2003). Control mechanism of the circadian clock for timing of cell division in vivo. Science, 302:255-259. [DOI] [PubMed] [Google Scholar]
  • [37].Hergenhan S, Holtkamp S, Scheiermann C (2020). Molecular Interactions Between Components of the Circadian Clock and the Immune System. J Mol Biol, 432:3700-3713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Tokuda IT, Okamoto A, Matsumura R, Takumi T, Akashi M (2017). Potential contribution of tandem circadian enhancers to nonlinear oscillations in clock gene expression. Mol Biol Cell, 28:2333-2342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Cirino G, Fusco F, Imbimbo C, Mirone V (2006). Pharmacology of erectile dysfunction in man. Pharmacology & Therapeutics, 111:400-423. [DOI] [PubMed] [Google Scholar]
  • [40].Andersson KE (2011). Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev, 63:811-859. [DOI] [PubMed] [Google Scholar]
  • [41].Ruan K-H, Mohite A, So S-P, Ruan C-H (2013). Establishing novel prostacyclin-synthesizing cells with therapeutic potential against heart diseases. International Journal of Cardiology, 163:163-169. [DOI] [PubMed] [Google Scholar]
  • [42].Minhas S, Cartledge JJ, Eardley I, Joyce AD, Morrison JF (2001). The interaction of nitric oxide and prostaglandins in the control of corporal smooth muscle tone: evidence for production of a cyclooxygenase-derived endothelium-contracting factor. BJU Int, 87:882-888. [DOI] [PubMed] [Google Scholar]
  • [43].Shamloul R, Ghanem H (2013). Erectile dysfunction. Lancet, 381:153-165. [DOI] [PubMed] [Google Scholar]
  • [44].Hou JQ, Bozkurt A, Karabakan M, Aktas BK, Gunay M, Keskin E, et al. (2018). Low serum melatonin levels are associated with erectile dysfunction. Int Urol Nephrol, 44:794-799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [45].Cho JW, Duffy JF (2019). Sleep, Sleep Disorders, and Sexual Dysfunction. World J Mens Health, 37:261-275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [46].Man AWC, Li H, Xia N (2021). Circadian Rhythm: Potential Therapeutic Target for Atherosclerosis and Thrombosis. Int [J] Mol Sci. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Lue TF (2000). Erectile dysfunction. N Engl J Med, 342:1802-1813. [DOI] [PubMed] [Google Scholar]
  • [48].Pastuszak AW, Moon YM, Scovell J, Badal J, Lamb DJ, Link RE, et al. (2017). Poor Sleep Quality Predicts Hypogonadal Symptoms and Sexual Dysfunction in Male Nonstandard Shift Workers. Urology, 102:121-125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [49].Deng N, Haney NM, Kohn TP, Pastuszak AW, Lipshultz LI (2018). The Effect of Shift Work on Urogenital Disease: a Systematic Review. Curr Urol Rep, 19:57. [DOI] [PubMed] [Google Scholar]
  • [50].Andersen ML, Santos-Silva R, Bittencourt LR, Tufik S (2010). Prevalence of erectile dysfunction complaints associated with sleep disturbances in Sao Paulo, Brazil: a population-based survey. Sleep Med, 11:1019-1024. [DOI] [PubMed] [Google Scholar]
  • [51].Budweiser S, Enderlein S, Jörres RA, Hitzl AP, Wieland WF, Pfeifer M, et al. (2009). Sleep apnea is an independent correlate of erectile and sexual dysfunction. J Sex Med, 6:3147-3157. [DOI] [PubMed] [Google Scholar]
  • [52].Li Z, Tang T, Wu W, Gu L, Du J, Zhao T, et al. (2016). Efficacy of nasal continuous positive airway pressure on patients with OSA with erectile dysfunction and low sex hormone levels. Respir Med, 119:130-134. [DOI] [PubMed] [Google Scholar]
  • [53].Zhang XB, Lin QC, Zeng HQ, Jiang XT, Chen B, Chen X (2016). Erectile Dysfunction and Sexual Hormone Levels in Men With Obstructive Sleep Apnea: Efficacy of Continuous Positive Airway Pressure. Arch Sex Behav, 45:235-240. [DOI] [PubMed] [Google Scholar]
  • [54].Bisanti L, Olsen J, Basso O, Thonneau P, Karmaus W (1996). Shift work and subfecundity: a European multicenter study. European Study Group on Infertility and Subfecundity. J Occup Environ Med, 38:352-358. [DOI] [PubMed] [Google Scholar]
  • [55].Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, et al. (2015). National Sleep Foundation's sleep time duration recommendations: methodology and results summary. Sleep Health, 1:40-43. [DOI] [PubMed] [Google Scholar]
  • [56].Weingarten JA, Collop NA (2013). Air travel: effects of sleep deprivation and jet lag. Chest, 144:1394-1401. [DOI] [PubMed] [Google Scholar]
  • [57].Kling JM, Manson JE, Naughton MJ, Temkit M, Sullivan SD, Gower EW, et al. (2017). Association of sleep disturbance and sexual function in postmenopausal women. Menopause, 24:604-612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [58].Carrier S, Nagaraju P, Morgan DM, Baba K, Nunes L, Lue TF (1997). Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J Urol, 157:1088-1092. [PubMed] [Google Scholar]
  • [59].Li T, Wu C, Fu F, Xiong W, Qin F, Yuan J (2019). Long-Term Aspirin Administration Has No Effect on Erectile Function: Evidence from Adult Rats and Ageing Rat Model. Sci Rep, 9:7941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Amany S, Heba K (2013). Effect of pregabalin on erectile function and penile NOS expression in rats with streptozotocin-induced diabetes. Exp Clin Endocrinol Diabetes, 121:230-233. [DOI] [PubMed] [Google Scholar]
  • [61].Yuan J, Lin H, Li P, Zhang R, Luo A, Berardinelli F, et al. (2010). Molecular mechanisms of vacuum therapy in penile rehabilitation: a novel animal study. Eur Urol, 58:773-780. [DOI] [PubMed] [Google Scholar]
  • [62].Rodrigo GC, Herbert KE (2018). Regulation of vascular function and blood pressure by circadian variation in redox signalling. Free Radic Biol Med. [DOI] [PubMed] [Google Scholar]
  • [63].Shaw JA, Chin-Dusting JP, Kingwell BA, Dart AM (2001). Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation, 103:806-812. [DOI] [PubMed] [Google Scholar]
  • [64].Denniff M, Turrell HE, Vanezis A, Rodrigo GC (2014). The time-of-day variation in vascular smooth muscle contractility depends on a nitric oxide signalling pathway. J Mol Cell Cardiol, 66:133-140. [DOI] [PubMed] [Google Scholar]
  • [65].Anea CB, Cheng B, Sharma S, Kumar S, Caldwell RW, Yao L, et al. (2012). Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice. Circ Res, 111:1157-1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [66].Xie Z, Su W, Liu S, Zhao G, Esser K, Schroder EA, et al. (2015). Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation. J Clin Invest, 125:324-336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Viswambharan H, Carvas JM, Antic V, Marecic A, Jud C, Zaugg CE, et al. (2007). Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation, 115:2188-2195. [DOI] [PubMed] [Google Scholar]
  • [68].Carvas JM, Vukolic A, Yepuri G, Xiong Y, Popp K, Schmutz I, et al. (2012). Period2 gene mutant mice show compromised insulin-mediated endothelial nitric oxide release and altered glucose homeostasis. Front Physiol. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [69].Soukhova-O'Hare GK, Shah ZA, Lei Z, Nozdrachev AD, Rao CV, Gozal D (2008). Erectile dysfunction in a murine model of sleep apnea. Am J Respir Crit Care Med, 178:644-650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [70].Khan MA, Thompson CS, Mumtaz FH, Mikhailidis DP, Morgan RJ, Bruckdorfer RK, et al. (2001). The effect of nitric oxide and peroxynitrite on rabbit cavernosal smooth muscle relaxation. World J Urol, 19:220-224. [DOI] [PubMed] [Google Scholar]
  • [71].Beckman JS, Koppenol WH (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol, 271:C1424-1437. [DOI] [PubMed] [Google Scholar]
  • [72].Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K, et al. (2000). Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax, 55:1046-1051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [73].Karacan I, Karatas M (1995). Erectile dysfunction in sleep apnea and response to CPAP. J Sex Marital Ther, 21:239-247. [DOI] [PubMed] [Google Scholar]
  • [74].Lee DS, Choi JB, Sohn DW (2019). Impact of Sleep Deprivation on the Hypothalamic-Pituitary-Gonadal Axis and Erectile Tissue. J Sex Med, 16:5-16. [DOI] [PubMed] [Google Scholar]
  • [75].Castela Â, Costa C (2016). Molecular mechanisms associated with diabetic endothelial-erectile dysfunction. Nat Rev Urol, 13:266-274. [DOI] [PubMed] [Google Scholar]
  • [76].Endemann DH, Schiffrin EL (2004). Endothelial dysfunction. J Am Soc Nephrol, 15:1983-1992. [DOI] [PubMed] [Google Scholar]
  • [77].Anea CB, Zhang M, Stepp DW, Simkins GB, Reed G, Fulton DJ, et al. (2009). Vascular disease in mice with a dysfunctional circadian clock. Circulation. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [78].Anea CB, Cheng B, Sharma S, Kumar S, Caldwell RW, Yao L, et al. (2012). Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice. Circ Res. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [79].Viswambharan H, Carvas JM, Antic V, Marecic A, Jud C, Zaugg CE, et al. (2007). Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation. [DOI] [PubMed] [Google Scholar]
  • [80].Virag R, Bouilly P, Frydman D (1985). Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet, 1:181-184. [DOI] [PubMed] [Google Scholar]
  • [81].Gibbs J, Ince L, Matthews L, Mei J, Bell T, Yang N, et al. (2014). An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action. Nat Med, 20:919-926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [82].Gao Y, Meng D, Sun N, Zhu Z, Zhao R, Lu C, et al. (2014). Clock upregulates intercellular adhesion molecule-1 expression and promotes mononuclear cells adhesion to endothelial cells. Biochem Biophys Res Commun, 443:586-591. [DOI] [PubMed] [Google Scholar]
  • [83].Qin B, Deng Y (2015). Overexpression of circadian clock protein cryptochrome (CRY) 1 alleviates sleep deprivation-induced vascular inflammation in a mouse model. Immunol Lett, 163:76-83. [DOI] [PubMed] [Google Scholar]
  • [84].Westgate EJ, Cheng Y, Reilly DF, Price TS, Walisser JA, Bradfield CA, et al. (2008). Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation, 117:2087-2095. [DOI] [PubMed] [Google Scholar]
  • [85].Ninivaggi M, Kelchtermans H, Kuijpers MJ, Hemmeryckx B, Heemskerk JW, Lindhout T, et al. (2014). Whole blood thrombin generation in Bmal1-deficient mice. Thromb Haemost, 112:271-275. [DOI] [PubMed] [Google Scholar]
  • [86].Zhang X, Kanika ND, Melman A, DiSanto ME (2012). Smooth muscle myosin expression, isoform composition, and functional activities in rat corpus cavernosum altered by the streptozotocin-induced type 1 diabetes. Am J Physiol Endocrinol Metab, 302:E32-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [87].Wei AY, He SH, Zhao JF, liu Y, Liu Y, Hu YW, et al. (2012). Characterization of corpus cavernosum smooth muscle cell phenotype in diabetic rats with erectile dysfunction. Int J Impot Res, 24:196-201. [DOI] [PubMed] [Google Scholar]
  • [88].Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, et al. (2010). Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med, 7:445-475. [DOI] [PubMed] [Google Scholar]
  • [89].Elçioğlu HK, Kabasakal L, Özkan N, Çelikel Ç, Ayanoğlu-Dülger G (2011). A study comparing the effects of rosiglitazone and/or insulin treatments on streptozotocin induced diabetic (type I diabetes) rat aorta and cavernous tissues. Eur J Pharmacol, 660:476-484. [DOI] [PubMed] [Google Scholar]
  • [90].Kovanecz I, Nolazco G, Ferrini MG, Toblli JE, Heydarkhan S, Vernet D, et al. (2009). Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction. BJU Int, 103:1396-1404. [DOI] [PubMed] [Google Scholar]
  • [91].Lin C, Tang X, Zhu Z, Liao X, Zhao R, Fu W, et al. (2014). The rhythmic expression of clock genes attenuated in human plaque-derived vascular smooth muscle cells. Lipids Health Dis, 13:14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [92].Xie Z, Su W, Liu S, Zhao G, Esser K, Schroder EA, et al. (2015). Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation. [J] Clin Invest. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [93].Su W, Xie Z, Guo Z, Duncan MJ, Lutshumba J, Gong MC (2012). Altered clock gene expression and vascular smooth muscle diurnal contractile variations in type 2 diabetic db/db mice. Am J Physiol Heart Circ Physiol, 302:H621-633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [94].Chen S, Ding Y, Zhang Z, Wang H, Liu C (2014). Hyperlipidaemia impairs the circadian clock and physiological homeostasis of vascular smooth muscle cells via the suppression of Smarcd1. J Pathol, 233:159-169. [DOI] [PubMed] [Google Scholar]
  • [95].Chalmers JA, Martino TA, Tata N, Ralph MR, Sole MJ, Belsham DD (2008). Vascular circadian rhythms in a mouse vascular smooth muscle cell line (Movas-1). Am J Physiol Regul Integr Comp Physiol, 295:R1529-1538. [DOI] [PubMed] [Google Scholar]
  • [96].Lin HH, Ho FM, Chen YF, Tseng CM, Ho CC, Chung WS (2015). Increased risk of erectile dysfunction among patients with sleep disorders: a nationwide population-based cohort study. Int J Clin Pract, 69:846-852. [DOI] [PubMed] [Google Scholar]
  • [97].Kaya E, Sikka SC, Gur S (2015). A comprehensive review of metabolic syndrome affecting erectile dysfunction. J Sex Med, 12:856-875. [DOI] [PubMed] [Google Scholar]
  • [98].Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, et al. (2008). Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol, 51:2040-2044. [DOI] [PubMed] [Google Scholar]
  • [99].Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, et al. (2003). Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol, 44:360-364; discussion 364-365. [DOI] [PubMed] [Google Scholar]
  • [100].Kloner RA, Speakman M (2002). Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep. [DOI] [PubMed] [Google Scholar]
  • [101].Azadzoi KM, Goldstein I (1992). Erectile dysfunction due to atherosclerotic vascular disease: the development of an animal model. J Urol, 147:1675-1681. [DOI] [PubMed] [Google Scholar]
  • [102].Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Speizer FE, et al. (1995). Prospective study of shift work and risk of coronary heart disease in women. Circulation, 92:3178-3182. [DOI] [PubMed] [Google Scholar]
  • [103].Zhang C (2008). The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol, 103:398-406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [104].Libby P, Ridker PM, Maseri A (2002). Inflammation and atherosclerosis. Circulation, 105:1135-1143. [DOI] [PubMed] [Google Scholar]
  • [105].Nakazaki C, Noda A, Koike Y, Yamada S, Murohara T, Ozaki N (2012). Association of insomnia and short sleep duration with atherosclerosis risk in the elderly. Am J Hypertens, 25:1149-1155. [DOI] [PubMed] [Google Scholar]
  • [106].Reilly DF, Curtis AM, Cheng Y, Westgate EJ, Rudic RD, Paschos G, et al. (2008). Peripheral circadian clock rhythmicity is retained in the absence of adrenergic signaling. Arterioscler Thromb Vasc Biol, 28:121-126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [107].Pan X, Jiang XC, Hussain MM (2013). Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice. Circulation, 128:1758-1769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [108].Yang L, Chu Y, Wang L, Wang Y, Zhao X, He W, et al. (2015). Overexpression of CRY1 protects against the development of atherosclerosis via the TLR/NF-κB pathway. Int Immunopharmacol, 28:525-530. [DOI] [PubMed] [Google Scholar]
  • [109].Sitaula S, Billon C, Kamenecka TM, Solt LA, Burris TP (2015). Suppression of atherosclerosis by synthetic REV-ERB agonist. Biochem Biophys Res Commun, 460:566-571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [110].Anea CB, Zhang M, Stepp DW, Simkins GB, Reed G, Fulton DJ, et al. (2009). Vascular disease in mice with a dysfunctional circadian clock. Circulation, 119:1510-1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [111].Somanath PR, Podrez EA, Chen J, Ma Y, Marchant K, Antoch M, et al. (2011). Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype. J Cell Physiol, 226:132-140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [112].Xie M, Tang Q, Nie J, Zhang C, Zhou X, Yu S, et al. (2020). BMAL1-Downregulation Aggravates Porphyromonas Gingivalis-Induced Atherosclerosis by Encouraging Oxidative Stress. Circ Res, 126:e15-e29. [DOI] [PubMed] [Google Scholar]
  • [113].Cheng B, Anea CB, Yao L, Chen F, Patel V, Merloiu A, et al. (2011). Tissue-intrinsic dysfunction of circadian clock confers transplant arteriosclerosis. Proc Natl Acad Sci U S A, 108:17147-17152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [114].Ma H, Zhong W, Jiang Y, Fontaine C, Li S, Fu J, et al. (2013). Increased atherosclerotic lesions in LDL receptor deficient mice with hematopoietic nuclear receptor Rev-erbα knock- down. J Am Heart Assoc, 2:e000235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [115].Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994). Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol, 151:54-61. [DOI] [PubMed] [Google Scholar]
  • [116].Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ (2006). Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med, 166:207-212. [DOI] [PubMed] [Google Scholar]
  • [117].Chitaley K, Kupelian V, Subak L, Wessells H (2009). Diabetes, obesity and erectile dysfunction: field overview and research priorities. J Urol, 182:S45-50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [118].Malavige LS, Levy JC (2009). Erectile dysfunction in diabetes mellitus. J Sex Med, 6:1232-1247. [DOI] [PubMed] [Google Scholar]
  • [119].Hidalgo-Tamola J, Chitaley K (2009). Review type 2 diabetes mellitus and erectile dysfunction. J Sex Med, 6:916-926. [DOI] [PubMed] [Google Scholar]
  • [120].Rehman J, Chenven E, Brink P, Peterson B, Walcott B, Wen YP, et al. (1997). Diminished neurogenic but not pharmacological erections in the 2- to 3-month experimentally diabetic F-344 rat. Am J Physiol, 272:H1960-1971. [DOI] [PubMed] [Google Scholar]
  • [121].Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, et al. (1997). Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology, 50:1016-1026. [DOI] [PubMed] [Google Scholar]
  • [122].Cartledge JJ, Eardley I, Morrison JF (2000). Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin. BJU Int, 85:735-741. [DOI] [PubMed] [Google Scholar]
  • [123].Nangle MR, Cotter MA, Cameron NE (2003). Protein kinase C beta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice. Eur J Pharmacol, 475:99-106. [DOI] [PubMed] [Google Scholar]
  • [124].Nangle MR, Cotter MA, Cameron NE (2003). Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering. Diabetes, 52:2396-2402. [DOI] [PubMed] [Google Scholar]
  • [125].Gur S, Kadowitz PJ, Hellstrom WJ (2010). A protein tyrosine kinase inhibitor, imatinib mesylate (Gleevec), improves erectile and vascular function secondary to a reduction of hyperglycemia in diabetic rats. J Sex Med, 7:3341-3350. [DOI] [PubMed] [Google Scholar]
  • [126].Kalsbeek A, la Fleur S, Fliers E (2014). Circadian control of glucose metabolism. Mol Metab, 3:372-383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [127].Morris CJ, Yang JN, Garcia JI, Myers S, Bozzi I, Wang W, et al. (2015). Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans. Proc Natl Acad Sci U S A, 112:E2225-2234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [128].Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET, Beebe C, et al. (1988). Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med, 318:1231-1239. [DOI] [PubMed] [Google Scholar]
  • [129].Rutters F, Besson H, Walker M, Mari A, Konrad T, Nilsson PM, et al. (2016). The Association Between Sleep Duration, Insulin Sensitivity, and β-Cell Function: The EGIR-RISC Study. J Clin Endocrinol Metab, 101:3272-3280. [DOI] [PubMed] [Google Scholar]
  • [130].Buxton OM, Cain SW, O'Connor SP, Porter JH, Duffy JF, Wang W, et al. (2012). Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med, 4:129ra143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [131].Morris CJ, Purvis TE, Mistretta J, Scheer FA (2016). Effects of the Internal Circadian System and Circadian Misalignment on Glucose Tolerance in Chronic Shift Workers. J Clin Endocrinol Metab, 101:1066-1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [132].Pietroiusti A, Neri A, Somma G, Coppeta L, Iavicoli I, Bergamaschi A, et al. (2010). Incidence of metabolic syndrome among night-shift healthcare workers. Occup Environ Med, 67:54-57. [DOI] [PubMed] [Google Scholar]
  • [133].Vyas MV, Garg AX, Iansavichus AV, Costella J, Donner A, Laugsand LE, et al. (2012). Shift work and vascular events: systematic review and meta-analysis. Bmj, 345:e4800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [134].Fonken LK, Workman JL, Walton JC, Weil ZM, Morris JS, Haim A, et al. (2010). Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci U S A, 107:18664-18669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [135].Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, et al. (2005). Obesity and metabolic syndrome in circadian Clock mutant mice. Science, 308:1043-1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [136].Rudic RD, McNamara P, Curtis AM, Boston RC, Panda S, Hogenesch JB, et al. (2004). BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol, 2:e377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [137].Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, Ko CH, et al. (2010). Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature, 466:627-631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [138].Doi R, Oishi K, Ishida N (2010). CLOCK regulates circadian rhythms of hepatic glycogen synthesis through transcriptional activation of Gys2. J Biol Chem, 285:22114-22121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [139].Shi SQ, Ansari TS, McGuinness OP, Wasserman DH, Johnson CH (2013). Circadian disruption leads to insulin resistance and obesity. Curr Biol, 23:372-381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [140].Zani F, Breasson L, Becattini B, Vukolic A, Montani JP, Albrecht U, et al. (2013). PER2 promotes glucose storage to liver glycogen during feeding and acute fasting by inducing Gys2 PTG and G L expression. Mol Metab, 2:292-305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [141].Lamia KA, Papp SJ, Yu RT, Barish GD, Uhlenhaut NH, Jonker JW, et al. (2011). Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature, 480:552-556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [142].Delezie J, Dumont S, Dardente H, Oudart H, Gréchez-Cassiau A, Klosen P, et al. (2012). The nuclear receptor REV-ERBα is required for the daily balance of carbohydrate and lipid metabolism. Faseb j, 26:3321-3335. [DOI] [PubMed] [Google Scholar]
  • [143].Tao H, Li X, Qiu JF, Cui WZ, Sima YH, Xu SQ (2017). Inhibition of expression of the circadian clock gene Period causes metabolic abnormalities including repression of glycometabolism in Bombyx mori cells. Sci Rep, 7:46258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [144].Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN (1994). Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol, 140:930-937. [DOI] [PubMed] [Google Scholar]
  • [145].Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, et al. (2000). Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med, 30:328-338. [DOI] [PubMed] [Google Scholar]
  • [146].Azadzoi KM, Goldstein I, Siroky MB, Traish AM, Krane RJ, Saenz de Tejada I (1998). Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol, 160:2216-2222. [DOI] [PubMed] [Google Scholar]
  • [147].Adamovich Y, Rousso-Noori L, Zwighaft Z, Neufeld-Cohen A, Golik M, Kraut-Cohen J, et al. (2014). Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides. Cell Metab, 19:319-330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [148].Pan X, Hussain MM (2007). Diurnal regulation of microsomal triglyceride transfer protein and plasma lipid levels. J Biol Chem, 282:24707-24719. [DOI] [PubMed] [Google Scholar]
  • [149].Lumeng JC, Somashekar D, Appugliese D, Kaciroti N, Corwyn RF, Bradley RH (2007). Shorter sleep duration is associated with increased risk for being overweight at ages 9 to 12 years. Pediatrics, 120:1020-1029. [DOI] [PubMed] [Google Scholar]
  • [150].Spiegel K, Tasali E, Leproult R, Van Cauter E (2009). Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol, 5:253-261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [151].Chua EC, Shui G, Lee IT, Lau P, Tan LC, Yeo SC, et al. (2013). Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans. Proc Natl Acad Sci U S A, 110:14468-14473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [152].Vieira E, Ruano E, Figueroa AL, Aranda G, Momblan D, Carmona F, et al. (2014). Altered clock gene expression in obese visceral adipose tissue is associated with metabolic syndrome. PLoS One, 9:e111678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [153].Pan X, Bradfield CA, Hussain MM (2016). Global and hepatocyte-specific ablation of Bmal1 induces hyperlipidaemia and enhances atherosclerosis. Nat Commun, 7:13011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [154].Jacobi D, Liu S, Burkewitz K, Kory N, Knudsen NH, Alexander RK, et al. (2015). Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness. Cell Metab, 22:709-720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [155].Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, et al. (2012). Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature, 485:123-127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [156].Shimba S, Ogawa T, Hitosugi S, Ichihashi Y, Nakadaira Y, Kobayashi M, et al. (2011). Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS One, 6:e25231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [157].Grimaldi B, Bellet MM, Katada S, Astarita G, Hirayama J, Amin RH, et al. (2010). PER2 controls lipid metabolism by direct regulation of PPARγ. Cell Metab, 12:509-520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [158].Yang S, Liu A, Weidenhammer A, Cooksey RC, McClain D, Kim MK, et al. (2009). The role of mPer2 clock gene in glucocorticoid and feeding rhythms. Endocrinology, 150:2153-2160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [159].Dallmann R, Weaver DR (2010). Altered body mass regulation in male mPeriod mutant mice on high-fat diet. Chronobiol Int, 27:1317-1328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [160].Xing C, Huang X, Zhang Y, Zhang C, Wang W, Wu L, et al. (2020). Sleep Disturbance Induces Increased Cholesterol Level by NR1D1 Mediated CYP7A1 Inhibition. Front Genet. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [161].Le Martelot G, Claudel T, Gatfield D, Schaad O, Kornmann B, Lo Sasso G, et al. (2009). REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol, 7:e1000181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [162].Keast JR, Saunders RJ (1998). Testosterone has potent, selective effects on the morphology of pelvic autonomic neurons which control the bladder, lower bowel and internal reproductive organs of the male rat. Neuroscience, 85:543-556. [DOI] [PubMed] [Google Scholar]
  • [163].Traish AM, Goldstein I, Kim NN (2007). Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol, 52:54-70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [164].Traish A, Kim N (2005). The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J Sex Med, 2:759-770. [DOI] [PubMed] [Google Scholar]
  • [165].Shen ZJ, Zhou XL, Lu YL, Chen ZD (2003). Effect of androgen deprivation on penile ultrastructure. Asian J Androl, 5:33-36. [PubMed] [Google Scholar]
  • [166].Tomada I, Tomada N, Almeida H, Neves D (2013). Androgen depletion in humans leads to cavernous tissue reorganization and upregulation of Sirt1-eNOS axis. Age (Dordr), 35:35-47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [167].Shabsigh R (1997). The effects of testosterone on the cavernous tissue and erectile function. World J Urol, 15:21-26. [DOI] [PubMed] [Google Scholar]
  • [168].Baba K, Yajima M, Carrier S, Morgan DM, Nunes L, Lue TF, et al. (2000). Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis. BJU Int, 85:953-958. [DOI] [PubMed] [Google Scholar]
  • [169].Mills TM, Stopper VS, Wiedmeier VT (1994). Effects of castration and androgen replacement on the hemodynamics of penile erection in the rat. Biol Reprod, 51:234-238. [DOI] [PubMed] [Google Scholar]
  • [170].Filippi S, Vignozzi L, Morelli A, Chavalmane AK, Sarchielli E, Fibbi B, et al. (2009). Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. J Sex Med, 6:3274-3288. [DOI] [PubMed] [Google Scholar]
  • [171].Luboshitzky R, Zabari Z, Shen-Orr Z, Herer P, Lavie P (2001). Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab, 86:1134-1139. [DOI] [PubMed] [Google Scholar]
  • [172].Wittert G (2014). The relationship between sleep disorders and testosterone in men. Asian J Androl, 16:262-265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [173].Wittert G (2014). The relationship between sleep disorders and testosterone. Curr Opin Endocrinol Diabetes Obes, 21:239-243. [DOI] [PubMed] [Google Scholar]
  • [174].Leproult R, Van Cauter E (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. Jama, 305:2173-2174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [175].Cote KA, McCormick CM, Geniole SN, Renn RP, MacAulay SD (2013). Sleep deprivation lowers reactive aggression and testosterone in men. Biol Psychol, 92:249-256. [DOI] [PubMed] [Google Scholar]
  • [176].Andersen ML TS (2008). The effects of testosterone on sleep and sleep-disordered breathing in men: its bidirectional interaction with erectile function. Sleep Med Rev, 12:365-379. [DOI] [PubMed] [Google Scholar]
  • [177].Axelsson J, Akerstedt T, Kecklund G, Lindqvist A, Attefors R (2003). Hormonal changes in satisfied and dissatisfied shift workers across a shift cycle. J Appl Physiol (1985), 95:2099-2105. [DOI] [PubMed] [Google Scholar]
  • [178].Opstad PK (1992). Androgenic hormones during prolonged physical stress, sleep, and energy deficiency. J Clin Endocrinol Metab, 74:1176-1183. [DOI] [PubMed] [Google Scholar]
  • [179].Wu JL, Wu RS, Yang JG, Huang CC, Chen KB, Fang KH, et al. (2011). Effects of sleep deprivation on serum testosterone concentrations in the rat. Neurosci Lett, 494:124-129. [DOI] [PubMed] [Google Scholar]

Articles from Aging and Disease are provided here courtesy of JKL International LLC

RESOURCES